<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01554241</url>
  </required_header>
  <id_info>
    <org_study_id>DinNH2012</org_study_id>
    <secondary_id>1R21AG04166001-A1</secondary_id>
    <secondary_id>additional funder</secondary_id>
    <nct_id>NCT01554241</nct_id>
  </id_info>
  <brief_title>Optimizing Vitamin D in the Elderly</brief_title>
  <official_title>Optimizing Vitamin D in the Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D deficiency is highly prevalent in older people in the absence of vitamin D
      supplementation. The limited data available show marked inter-individual variability in
      response to vitamin D supplementation in very old, frail elderly with almost 25% remaining
      vitamin D deficient (25-OH D &lt; 20 ng/mL) when receiving the currently recommended 800 IU/day
      vitamin D. This proposal is for exploratory research on the use of a wide range of oral
      vitamin D3 doses in frail elderly living in controlled living environments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will determine the dose response relationship of circulating total and
      unbound 25-OH vitamin D3 to supplemental vitamin D3 at daily doses of 800 (currently
      recommended for the elderly), 2000, and 4000 IU or 50,000 IU/weekly in a randomized blinded
      investigation of 16 weeks duration. The investigators will also compare the efficacy of each
      dosing regimen in achieving 25-OH vitamin D levels &gt;20 ng/mL (50 nmol/L) and identify
      covariates that contribute to inter-individual variation in the dose response relationship.
      In patients with osteoporosis, relationships between unbound vs. total 25-OH on intact
      parathyroid hormone and a marker of bone resorption (beta-Ctx) will be analyzed. The
      investigators will also examine responses of inflammatory cytokines.

      Note: as of April 8,2014, there will be no further enrollment in the 50,000 IU/weekly dose
      group
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total 25-OH Vitamin D3 Level</measure>
    <time_frame>16 weeks</time_frame>
    <description>circulating total 25-OH vitamin D concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Free 25-OH Vitamin D3</measure>
    <time_frame>16 weeks</time_frame>
    <description>circulating free 25-OH vitamin D3 concentration</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Deficiency of Vitamin D3</condition>
  <arm_group>
    <arm_group_label>vitamin D3 800 IU/day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>recommended daily dosage of 800 IU/day D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2000 IU/day D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>D3 2000 IU/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin D3 4000 IU/day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>D3 4000 IU/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>50,000 IU/week D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>D3 50,000 IU weekly</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>D3 2000 IU/day</intervention_name>
    <description>2000 IU/day D3</description>
    <arm_group_label>2000 IU/day D3</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>D3 4000 IU/day</intervention_name>
    <description>vitamin D3 4000 IU/day</description>
    <arm_group_label>vitamin D3 4000 IU/day</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>D3 50,000 IU weekly</intervention_name>
    <description>vitamin D3 50,000 IU/week</description>
    <arm_group_label>50,000 IU/week D3</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3 800 IU/day</intervention_name>
    <description>vitamin D3 800 IU/day</description>
    <arm_group_label>vitamin D3 800 IU/day</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age over 65

          -  medically stable

          -  residing in long-term care or assisted living

        Exclusion Criteria:

          -  hypercalcemia or high risk for hypercalcemia

          -  active cancer or malignancy other than non-melanoma skin cancer

          -  severe renal disease (eGFR &lt;30 ml/mkin/M2)

          -  small bowel resection or intestinal bypass surgery

          -  hyperparathyroidism

          -  granulomatous disease

          -  clinically unstable (changes in medications or diagnoses within a month,
             hospitalizations, within 6 months)

          -  allergy to vitamin D
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janice B Schwartz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2012</study_first_posted>
  <results_first_submitted>January 23, 2015</results_first_submitted>
  <results_first_submitted_qc>February 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 18, 2015</results_first_posted>
  <last_update_submitted>February 13, 2015</last_update_submitted>
  <last_update_submitted_qc>February 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D3</keyword>
  <keyword>D3</keyword>
  <keyword>cholecalciferol</keyword>
  <keyword>25-OH vitamin D</keyword>
  <keyword>elderly</keyword>
  <keyword>nursing home resident</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Following participant consent/enrollment, 4 were ineligible due to clinical instability or abnormal laboratory tests and one withdrew consent.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Vitamin D3 800 IU/Day</title>
          <description>recommended daily dosage of 800 IU/day D3
vitamin D3 800 IU/day: vitamin D3 800 IU/day</description>
        </group>
        <group group_id="P2">
          <title>2000 IU/Day D3</title>
          <description>D3 2000 IU/day
D3 2000 IU/day: 2000 IU/day D3</description>
        </group>
        <group group_id="P3">
          <title>Vitamin D3 4000 IU/Day</title>
          <description>D3 4000 IU/day
D3 4000 IU/day: vitamin D3 4000 IU/day</description>
        </group>
        <group group_id="P4">
          <title>50,000 IU/Week D3</title>
          <description>D3 50,000 IU weekly
D3 50,000 IU weekly: vitamin D3 50,000 IU/week</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="24"/>
                <participants group_id="P4" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="19"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>protocol specified renal stone</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>protocol specified change in eGFR</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Elderly (&gt;65 yr) clinically stable long-term stay nursing home residents with no contraindications or allergy to D, osteoporosis or a history of fractures and receiving over 800 IU/day D, treatment for severe D deficiency or investigational agent in the prior six months on no D or had stable D doses for over two months .</population>
      <group_list>
        <group group_id="B1">
          <title>Vitamin D3 800 IU/Day</title>
          <description>recommended daily dosage of 800 IU/day D3
vitamin D3 800 IU/day: vitamin D3 800 IU/day</description>
        </group>
        <group group_id="B2">
          <title>2000 IU/Day D3</title>
          <description>D3 2000 IU/day
D3 2000 IU/day: 2000 IU/day D3</description>
        </group>
        <group group_id="B3">
          <title>Vitamin D3 4000 IU/Day</title>
          <description>D3 4000 IU/day
D3 4000 IU/day: vitamin D3 4000 IU/day</description>
        </group>
        <group group_id="B4">
          <title>50,000 IU/Week D3</title>
          <description>D3 50,000 IU weekly
D3 50,000 IU weekly: vitamin D3 50,000 IU/week</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="24"/>
            <count group_id="B4" value="14"/>
            <count group_id="B5" value="81"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84.9" spread="8.7"/>
                    <measurement group_id="B2" value="85.9" spread="8.5"/>
                    <measurement group_id="B3" value="89.5" spread="6.6"/>
                    <measurement group_id="B4" value="90.1" spread="6.6"/>
                    <measurement group_id="B5" value="87.4" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total 25-OH Vitamin D3 Level</title>
        <description>circulating total 25-OH vitamin D concentration</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D3 800 IU/Day</title>
            <description>recommended daily dosage of 800 IU/day D3
vitamin D3 800 IU/day: vitamin D3 800 IU/day</description>
          </group>
          <group group_id="O2">
            <title>2000 IU/Day D3</title>
            <description>D3 2000 IU/day
D3 2000 IU/day: 2000 IU/day D3</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D3 4000 IU/Day</title>
            <description>D3 4000 IU/day
D3 4000 IU/day: vitamin D3 4000 IU/day</description>
          </group>
          <group group_id="O4">
            <title>50,000 IU/Week D3</title>
            <description>D3 50,000 IU weekly
D3 50,000 IU weekly: vitamin D3 50,000 IU/week</description>
          </group>
        </group_list>
        <measure>
          <title>Total 25-OH Vitamin D3 Level</title>
          <description>circulating total 25-OH vitamin D concentration</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" spread="6"/>
                    <measurement group_id="O2" value="34" spread="6"/>
                    <measurement group_id="O3" value="43" spread="10"/>
                    <measurement group_id="O4" value="61" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Comparisons of concentrations in D3 dosing groups at study end were made by ANOVA. Adherence of 80% was pre-specified for inclusion in analyses. .</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
            <method_desc>Results presented were Bonferonni-corrected for a mid-point safety analysis</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=.56</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0009</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.006</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Free 25-OH Vitamin D3</title>
        <description>circulating free 25-OH vitamin D3 concentration</description>
        <time_frame>16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D3 800 IU/Day</title>
            <description>recommended daily dosage of 800 IU/day D3
vitamin D3 800 IU/day: vitamin D3 800 IU/day</description>
          </group>
          <group group_id="O2">
            <title>2000 IU/Day D3</title>
            <description>D3 2000 IU/day
D3 2000 IU/day: 2000 IU/day D3</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D3 4000 IU/Day</title>
            <description>D3 4000 IU/day
D3 4000 IU/day: vitamin D3 4000 IU/day</description>
          </group>
          <group group_id="O4">
            <title>50,000 IU/Week D3</title>
            <description>D3 50,000 IU weekly
D3 50,000 IU weekly: vitamin D3 50,000 IU/week</description>
          </group>
        </group_list>
        <measure>
          <title>Free 25-OH Vitamin D3</title>
          <description>circulating free 25-OH vitamin D3 concentration</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="19"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="2.1"/>
                    <measurement group_id="O2" value="9.5" spread="1.7"/>
                    <measurement group_id="O3" value="12.2" spread="4.3"/>
                    <measurement group_id="O4" value="16.8" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>analyses were corrected for multiple comparisons (Bonferroni)</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.47</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.002</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.02</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0003</p_value>
            <method>ANOVA</method>
            <method_desc>Bonferroni/Dunn adjustment</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>16 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Vitamin D3 800 IU/Day</title>
          <description>recommended daily dosage of 800 IU/day D3
vitamin D3 800 IU/day: vitamin D3 800 IU/day</description>
        </group>
        <group group_id="E2">
          <title>2000 IU/Day D3</title>
          <description>D3 2000 IU/day
D3 2000 IU/day: 2000 IU/day D3</description>
        </group>
        <group group_id="E3">
          <title>Vitamin D3 4000 IU/Day</title>
          <description>D3 4000 IU/day
D3 4000 IU/day: vitamin D3 4000 IU/day</description>
        </group>
        <group group_id="E4">
          <title>50,000 IU/Week D3</title>
          <description>D3 50,000 IU weekly
D3 50,000 IU weekly: vitamin D3 50,000 IU/week</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>hyperbilirubinemia</sub_title>
                <description>biliary obstruction</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>flu/pneumonia/sepsis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>fall + fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>renal complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>serious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ER visit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Janice B.Schwartz, M.D., Professor of Medicine</name_or_title>
      <organization>University of California, San Francisco</organization>
      <phone>(415) 406-1573</phone>
      <email>janice.schwartz@ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

